(Total Views: 442)
Posted On: 06/27/2020 1:24:25 PM
Post# of 36564
Re: Paul Jackson #17703
What I am trying to make sense of is how can NGIO be valued at $1.2-1.6 billion if there is no further news. Right now Gnbt is valued at around $50 million and it has stayed that way.
If NGIO as a subsidiary of Gnbt owns 90% of NGIO then its value will increase by from $1.08 -1.44 billion.
Between now and July 10th, I hope there is a press release that says we got a substantial amount of money from BARDA or CEPI to move forward with the vaccine.
We have a number of other outstanding products, including the possible purchase of Altucell, but without funds nothing is happening.
Let's hope we will get a press release that provides more substantive information. The only thing I have seen so far is that someone may invest up to $50 million in NGIO and that we may do a $33 million preferred stock offering paying 13% with a sinking fund.
Looking forward to some outstanding news.
If NGIO as a subsidiary of Gnbt owns 90% of NGIO then its value will increase by from $1.08 -1.44 billion.
Between now and July 10th, I hope there is a press release that says we got a substantial amount of money from BARDA or CEPI to move forward with the vaccine.
We have a number of other outstanding products, including the possible purchase of Altucell, but without funds nothing is happening.
Let's hope we will get a press release that provides more substantive information. The only thing I have seen so far is that someone may invest up to $50 million in NGIO and that we may do a $33 million preferred stock offering paying 13% with a sinking fund.
Looking forward to some outstanding news.
(3)
(0)
